H1B Visa Data for Nana Otutua Amoah: Cases Handled,Cases Certified, Approval Rate

We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Nana Otutua Amoah has been assisting clients through the H1B Visa process since 2021.

As of 2022, Nana Otutua Amoah has succesfully submitted and recieved certification for 280 cases.

Nana Otutua Amoah is located in Chicago, IL, and has represented 15 employers for the H1B Visa Process

322
Cases Handled

280
Cases Certified

86.96%
Approval

Cases Handled by Nana Otutua Amoah

Case Number	Case Status	Job Title	Industry Name	Employer Name	Year
I-200-24347-539829	Certified	Commercial And Industrial Designers	Pharmaceutical Preparation Manufacturing	Takeda Development Center Americas Inc	2025
I-200-24037-697052	Certified	Biological Technicians	Pharmaceutical Preparation Manufacturing	Takeda Development Center Americas Inc	2024
I-200-24241-299385	Certified	Biological Technicians	Pharmaceutical And Medicine Manufacturing	Shire Human Genetic Therapies Inc	2024
I-200-24088-836208	Certified	Economists	Commercial And Industrial Machinery And Equipment Except Automotive And Electronic Repair And Maintenance	Ww Grainger Inc	2024
I-200-24274-375022	Certified	Chemists	Pharmaceutical Preparation Manufacturing	Takeda Development Center Americas Inc	2025
I-200-24257-336802	Certified	Chemists	Pharmaceutical Preparation Manufacturing	Takeda Development Center Americas Inc	2024
I-200-24040-707288	Certified	Chemists	Pharmaceutical Preparation Manufacturing	Takeda Development Center Americas Inc	2024
I-200-22010-819463	Certified	Chemists	Pharmaceutical And Medicine Manufacturing	Takeda Development Center Americas Inc	2022
I-200-21222-512425	Certified	Chemists	Pharmaceutical And Medicine Manufacturing	Takeda Development Center Americas Inc	2021
I-200-21207-482764	Certified	Chemists	Pharmaceutical And Medicine Manufacturing	Shire Human Genetic Therapies Inc	2021